Trial · NCT02931539
Participant flow33
How many started, completed or left each group, period by period.
1 to 20 of 33
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Period 1: Treatment Phase | STARTED | Investigator-assigned Anti-CMV Treatment (IAT) | 117 | |
| Period 1: Treatment Phase | STARTED | Maribavir 400 mg | 235 | |
| Period 1: Treatment Phase | STARTED | Maribavir Rescue Arm | 0 | |
| Period 1: Treatment Phase | Treated Participants | Investigator-assigned Anti-CMV Treatment (IAT) | 116 | |
| Period 1: Treatment Phase | Treated Participants | Maribavir 400 mg | 234 | |
| Period 1: Treatment Phase | Treated Participants | Maribavir Rescue Arm | 0 | |
| Period 1: Treatment Phase | IAT (Ganciclovir/ Valganciclovir) | Investigator-assigned Anti-CMV Treatment (IAT) | 56 | |
| Period 1: Treatment Phase | IAT (Ganciclovir/ Valganciclovir) | Maribavir 400 mg | 0 | |
| Period 1: Treatment Phase | IAT (Ganciclovir/ Valganciclovir) | Maribavir Rescue Arm | 0 | |
| Period 1: Treatment Phase | IAT (Foscarnet) | Investigator-assigned Anti-CMV Treatment (IAT) | 47 | |
| Period 1: Treatment Phase | IAT (Foscarnet) | Maribavir 400 mg | 0 | |
| Period 1: Treatment Phase | IAT (Foscarnet) | Maribavir Rescue Arm | 0 | |
| Period 1: Treatment Phase | IAT (Cidofovir) | Investigator-assigned Anti-CMV Treatment (IAT) | 6 | |
| Period 1: Treatment Phase | IAT (Cidofovir) | Maribavir 400 mg | 0 | |
| Period 1: Treatment Phase | IAT (Cidofovir) | Maribavir Rescue Arm | 0 | |
| Period 1: Treatment Phase | IAT (Foscarnet + Valganciclovir/Ganciclovir) | Investigator-assigned Anti-CMV Treatment (IAT) | 7 | |
| Period 1: Treatment Phase | IAT (Foscarnet + Valganciclovir/Ganciclovir) | Maribavir 400 mg | 0 | |
| Period 1: Treatment Phase | IAT (Foscarnet + Valganciclovir/Ganciclovir) | Maribavir Rescue Arm | 0 | |
| Period 1: Treatment Phase | COMPLETED | Investigator-assigned Anti-CMV Treatment (IAT) | 58 | |
| Period 1: Treatment Phase | COMPLETED | Maribavir 400 mg | 199 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02931539/flow